Your browser doesn't support javascript.
loading
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
Peters, Niek A; Constantinides, Alexander; Ubink, Inge; van Kuik, Joyce; Bloemendal, Haiko J; van Dodewaard, Joyce M; Brink, Menno A; Schwartz, Thijs P; Lolkema, Martijn P J K; Lacle, Miangela M; Moons, Leon M; Geesing, Joost; van Grevenstein, Wilhelmina M U; Roodhart, Jeanine M L; Koopman, Miriam; Elias, Sjoerd G; Borel Rinkes, Inne H M; Kranenburg, Onno.
Affiliation
  • Peters NA; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Constantinides A; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Ubink I; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • van Kuik J; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Bloemendal HJ; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands.
  • van Dodewaard JM; Department of Internal Medicine/Oncology, Radboud University Medical Center Nijmegen, Nijmegen, Netherlands.
  • Brink MA; Department of Internal Medicine, Meander Medical Center, Amersfoort, Netherlands.
  • Schwartz TP; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands.
  • Lolkema MPJK; Department of Gastroenterology, Meander Medical Center, Amersfoort, Netherlands.
  • Lacle MM; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, Netherlands.
  • Moons LM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Geesing J; Department of Gastroenterology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • van Grevenstein WMU; Department of Gastroenterology, Diakonessenhuis, Utrecht, Netherlands.
  • Roodhart JML; Department of Surgical Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Koopman M; Lab Translational Oncology, Division of Imaging and Cancer, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Elias SG; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Borel Rinkes IHM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
  • Kranenburg O; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Front Oncol ; 12: 969855, 2022.
Article in En | MEDLINE | ID: mdl-36147916
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication: